Nav: Home

International 15-year study shows most dominant HIV subtype is also 'wimpiest'

October 13, 2016

An international study 15 years in the making has shown that it's 'survival of the wimpiest' among subtypes and strains when it comes to understanding the spread of HIV/AIDS around the world, a virus that has killed an estimated 35 million people since the 1970s.

Dating back to the early 2000s, Eric Arts, Chair of the Department of Microbiology & Immunology at Western University's Schulich School of Medicine & Dentistry, co-led a research team that monitored approximately 300 women in Uganda and Zimbabwe newly infected with HIV and examined their physical and mental health, as well as their social and behavioural patterns, for close to a decade in some cases.

Arts and his collaborators discovered that a group of infected women progressed very slowly to AIDS and discovered that nearly all were infected with a specific HIV-1 strain, called subtype C. This HIV-1 strain replicates very poorly and very slowly in patients making it the "wimpiest" subtype of the deadly virus despite also being the most dominant form of HIV in the world, predominantly found in Southern Africa, Eastern Africa, India, Nepal, and parts of Brazil and China.

These findings, published today by the journal EBioMedicine, appear counterintuitive to Darwinian evolutionary theory, which promotes the fittest not the wimpiest as the standard for reproductive success.

For video, images, maps and more, please visit http://mediarelations.uwo.ca/2016/10/13/international-15-year-study-shows-dominant-hiv-subtype-also-wimpiest/

"Understanding that HIV subtype C is 'wimpy' is a difficult proposition because seeing it replicate poorly in tissue culture flasks does not mean that it will establish a slower infection in an infected individual. But that's exactly what happens," explains Arts, the Tier 1 Canada Research Chair in HIV Pathogenesis and Viral Control. "Based on our study, it is very clear that patients infected with HIV subtype C progress slower to full-blown AIDS."

Arts led the study with collaborators from Western, Case Western Reserve University, the Joint Clinical Research Centre in Kampala, Uganda, Makerere University in Kampala, Uganda, the University of Zimbabwe, and Family Health International 360.

Colin Venner, a graduate student in the Arts Lab and lead author of the study, says that the growth of HIV subtype C from the early 1990s to where it is now has been very pronounced.

"A lot of people see the dramatic growth of HIV subtype C and think it would be the strongest virus and that it's beating all of the other subtypes but really, viruses are commonly transmitted, especially in southern and eastern Africa, in a period of asymptomatic disease," explains Venner. "These patients are maybe not aware that they're infected and that's when they're transmitting the most. The longer a patient is asymptomatic, the more likely they are to transmit to others is one of the thoughts that we're working on right now."

Arts believes knowing the virulence of the different HIV subtypes could have a major impact on how the virus is treated with drugs throughout the world.

"Unfortunately, we still don't have a vaccine that is effective in protecting against HIV but in treatment, if we know a patient progresses very slow to disease and the virus is having a minimal impact on the immune system then all of the devastating consequences of delaying treatment, as we saw in North America, may not be as pronounced in patients infected with HIV subtype C," offers Arts. "When we are looking at billions and billions of dollars a year to treat the global epidemic, we might have to look it as who needs treatment immediately and who can be delayed. That's very controversial but it's something that we have to consider for further study."
-end-
MEDIA CONTACT: Jeff Renaud, Senior Media Relations Officer, 519-661-2111, ext. 85165, jrenaud9@uwo.ca, @jeffrenaud99

ABOUT WESTERN

Western University delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.

Follow Western Media Relations online:

Website: http://communications.uwo.ca/media/

RSS: http://feeds.feedburner.com/MediaWesternU

Twitter: https://twitter.com/mediawesternu

University of Western Ontario

Related Hiv Articles:

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).
Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.
Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.
The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.
The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.
Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
First ever living donor HIV-to-HIV kidney transplant
For the first time, a person living with HIV has donated a kidney to a transplant recipient also living with HIV.
The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.
Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.
More HIV News and HIV Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.